Schonfeld Strategic Advisors LLC - AIM IMMUNOTECH INC ownership

Back to all holdings Add to watchlist

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 43 filers reported holding AIM IMMUNOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2022$11,000
+10.0%
10,800
-2.7%
0.00%–
Q4 2021$10,000
-56.5%
11,100
-0.9%
0.00%–
Q3 2021$23,000
-53.1%
11,200
-51.5%
0.00%
-100.0%
Q2 2021$49,000
-44.3%
23,100
-40.0%
0.00%0.0%
Q1 2021$88,000–38,500–0.00%–
 Download
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders